Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Therapeutic depletion of monocyte-derived cells protects from long-term axonal loss in experimental autoimmune encephalomyelitis.
Targeting specific cells in the brain with nanomedicines for CNS therapies.
Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes.
Relevance of endoglin, IL-1α, IL-1β and anti-ovarian antibodies in females with multiple sclerosis.
Advances in biomarker research in multiple sclerosis.
Good cardiac safety in patients with relapsing remitting multiple sclerosis upon first fingolimod dose.
Prefrontal tDCS Decreases Pain in Patients with Multiple Sclerosis.
A clinical update on the significance of the gut microbiota in systemic autoimmunity.
A Comparison of Stated Preferences for Injectable Disease-Modifying Treatments for Multiple Sclerosis: Compliant Vs. Non-Compliant Patients.
Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran.
Methylene blue alleviates experimental autoimmune encephalomyelitis by modulating AMPK/SIRT1 signaling pathway and Th17/Treg immune response.
The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
X-ray radiation and the risk of multiple sclerosis: Do the site and dose of exposure matter?
Central remyelination restores secure conduction.
[Pathology, diagnosis, and treatment of combined central and peripheral demyelination].
Fatal herpes encephalitis in a patient with small cell lung cancer following prophylactic cranial radiation - a case report with review of literature.
Neurological findings in incontinentia pigmenti; a review.
Immunomodulation by vitamin D in multiple sclerosis: More than IL-17.
The Aqueous Fraction of Areca catechu Nut Ameliorates Demyelination in Prefrontal Cortex-Induced Depressive Symptoms and Cognitive Decline through Brain-Derived Neurotrophic Factor-Cyclic Adenosine Monophosphate Response Element-Binding Activation.
Neuromyelitis optica (NMO) and autoimmune thyroiditis.
Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients.
Relapses in multiple sclerosis: Relationship to disability.
B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation.
IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
Treatment adherence in multiple sclerosis: a survey of Belgian neurologists.
Pages
« first
‹ previous
…
680
681
682
683
684
685
686
687
688
…
next ›
last »